Literature DB >> 23206923

Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).

Stephen J Greene1, Muthiah Vaduganathan, Laura Lupi, Andrew P Ambrosy, Robert J Mentz, Marvin A Konstam, Savina Nodari, Haris P Subacius, Gregg C Fonarow, Robert O Bonow, Mihai Gheorghiade.   

Abstract

Lower cholesterol levels are associated with worse outcomes in patients with chronic heart failure (HF) and have been shown to predict in-hospital mortality. The relation between lipid profile and postdischarge outcomes in patients hospitalized for worsening HF is less clear. In this post hoc analysis of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST), 3,957 patients hospitalized for worsening HF with ejection fractions ≤40% were examined. Baseline total cholesterol and triglyceride levels were measured <48 hours after admission and evaluated as continuous variables. The primary end points of all-cause mortality and cardiovascular mortality or hospitalization for HF were compared using Cox regression models. Patient characteristics at randomization were also compared among quartiles of total cholesterol. Patients with lower total cholesterol tended to have lower blood pressure, ejection fractions, serum sodium, and albumin, and were more likely to have worse HF functional class, to have higher natriuretic peptide levels, and to have histories of diabetes mellitus, renal insufficiency, and coronary revascularization (all p values <0.001). After adjustment for baseline clinical risk factors, total cholesterol was predictive of all-cause mortality (hazard ratio 0.73, 95% confidence interval 0.63 to 0.85, p <0.001) and cardiovascular mortality or hospitalization for HF (hazard ratio 0.73, 95% confidence interval 0.66 to 0.82, p <0.001) at median follow-up of 9.9 months. Lower baseline triglyceride level was also associated with worse outcomes. In conclusion, lower baseline total cholesterol is correlated with a high-risk patient profile and is a marker of disease severity in patients hospitalized for worsening HF with reduced ejection fraction. Baseline total cholesterol and triglyceride levels are predictive of mortality and HF rehospitalization beyond traditional risk factors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206923     DOI: 10.1016/j.amjcard.2012.10.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Lipids, statins, and clinical outcomes in heart failure: rethinking the data.

Authors:  Muthiah Vaduganathan; Stephen J Greene; Andrew P Ambrosy; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

2.  THE ROLE OF NT PRO-BNP IN THE EVALUATION OF DIABETIC PATIENTS WITH HEART FAILURE.

Authors:  F I Fringu; A V Sitar-Taut; B Caloian; D Zdrenghea; D Comsa; G Gusetu; D Pop
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

3.  Prognostic value of DCTA scoring system in heart failure.

Authors:  Tian-Jun Zhao; Qian-Kun Yang; Li-Dan Bi; Jie Li; Chun-Yu Tan; Zhi-Lin Miao
Journal:  Herz       Date:  2020-10-21       Impact factor: 1.443

4.  The prognosis and therapeutic management of patients hospitalized for heart failure in 2010-2020.

Authors:  Otto Mayer; Jan Bruthans; Simona Bilkova; Jitka Seidlerova; Josef Jirak; Jan Filipovsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-04-20       Impact factor: 1.648

5.  Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.

Authors:  Amanda R Vest; Peter J Kennel; Dawn Maldonado; James B Young; Maria M Mountis; Yoshifumi Naka; Paolo C Colombo; Donna M Mancini; Randall C Starling; P Christian Schulze
Journal:  Circ Heart Fail       Date:  2016-09       Impact factor: 8.790

6.  Impact of admission serum total cholesterol level on in-hospital mortality in patients with acute aortic dissection.

Authors:  Xintian Liu; Xi Su; Hesong Zeng
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

7.  Cholesterol and triglyceride levels in midlife and risk of heart failure in women, a longitudinal study: the prospective population study of women in Gothenburg.

Authors:  Anna-Karin Halldin; Lauren Lissner; Bodil Lernfelt; Cecilia Björkelund
Journal:  BMJ Open       Date:  2020-06-04       Impact factor: 2.692

Review 8.  Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.

Authors:  Matthew M Y Lee; Naveed Sattar; John J V McMurray; Chris J Packard
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 9.  Epidemiology of Heart Disease of Uncertain Etiology: A Population Study and Review of the Problem.

Authors:  Alessandro Menotti; Paolo Emilio Puddu
Journal:  Medicina (Kaunas)       Date:  2019-10-14       Impact factor: 2.430

10.  Change in lipid profile and risk of new-onset atrial fibrillation in patients with chronic heart failure: A 3-year follow-up observational study in a large Chinese hospital.

Authors:  Chen Liu; Jin Geng; Xiao Ye; Xiaochen Yuan; Aihua Li; Zhengang Zhang; Biao Xu; Yingwei Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.